Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Trimodality therapy was often selected due to patient preference and comorbidities, with 91% receiving planned radiation doses of 60 Gy or greater. Common severe NAC-related toxicities included ...